Fortrea Holdings Inc. (FTRE) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 12 analysts18.7% Below Target
FTRE trades 18.7% below Wall Street's consensus target of $18.17.
Current Price$15.31
Average Target$18.17
Target
Current
Low$14.00
Median$17.50
High$25.00
Analyst Target Range
Forward P/E19.2x
(Fair)
PEG Ratio—
Implied Growth+116.3%
(High Growth)
Analyst Spread60.5%
(Wide Disagreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes FTRE achieves its forward estimates and maintains a stable P/E multiple of 19.2x. This scenario reflects the blended consensus of 12 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
FTRE Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Fortrea Holdings Inc. (FTRE) has a Wall Street consensus price target of $18.17, based on estimates from 12 covering analysts. With the stock currently trading at $15.31, this represents a potential upside of +18.7%. The company has a market capitalization of $1.45B.
Analyst price targets range from a low of $14.00 to a high of $25.00, representing a 61% spread in expectations. The median target of $17.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, FTRE trades at a trailing P/E of -1.4x and forward P/E of 19.2x. Analysts expect EPS to grow +116.3% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+19.9%
Industry Consensus
Avg Forward P/E
17.7x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 IQVIQVIA Holdings Inc. | $28.5B | $167.77 | $219.44 | +30.8% | Buy | 13.1x | 44 |
 CRLCharles River Laboratories International, Inc. | $8.9B | $185.00 | $214.14 | +15.8% | Buy | 16.7x | 37 |
 MEDPMedpace Holdings, Inc. | $13.1B | $460.20 | $498.86 | +8.4% | Hold | 27.1x | 19 |
 PRAProAssurance Corporation | $1.3B | $24.65 | $18.33 | -25.6% | Hold | 20.1x | 11 |
 ICLRICON Public Limited Company | $11.2B | $146.00 | $139.90 | -4.2% | Buy | 13.8x | 30 |
 LHLabcorp Holdings Inc. | $21.1B | $255.82 | $311.33 | +21.7% | Buy | 14.2x | 35 |
 DGXQuest Diagnostics Incorporated | $21.6B | $195.00 | $220.57 | +13.1% | Hold | 18.1x | 34 |
 NVCRNovoCure Limited | $1.6B | $14.28 | $33.00 | +131.1% | Buy | — | 15 |
 HIMSHims & Hers Health, Inc. | $7.8B | $35.47 | $28.08 | -20.8% | Hold | — | 20 |
 TMOThermo Fisher Scientific Inc. | $172.7B | $464.61 | $599.70 | +29.1% | Buy | 18.7x | 42 |
FTRE — Frequently Asked Questions
Quick answers to the most common questions about buying FTRE stock.
What is the FTRE stock price target for 2026?
Fortrea Holdings Inc. (FTRE) has a consensus 12-month price target of $18.17, implying 18.7% upside from $15.31. The 12 analysts covering FTRE see moderate appreciation potential.
Is FTRE a buy, sell, or hold?
FTRE has a consensus rating of "Hold" based on 12 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $18.17 implies 18.7% upside from current levels.
Is FTRE stock overvalued or undervalued?
With a forward P/E of 19.2047x, FTRE trades at a relatively low valuation. The consensus target of $18.17 implies 18.7% appreciation, suggesting meaningful undervaluation.
How high can FTRE stock go?
The most bullish Wall Street analyst has a price target of $25 for FTRE, while the most conservative target is $14. The consensus of $18.17 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover FTRE stock?
FTRE is moderately covered, with 12 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the FTRE stock forecast?
The 12-month FTRE stock forecast based on 12 Wall Street analysts shows a consensus price target of $18.17, with estimates ranging from $14 (bear case) to $25 (bull case). The median consensus rating is "Hold".
What is FTRE's forward P/E ratio?
FTRE trades at a forward P/E ratio of 19.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy FTRE stock?
Wall Street analysts are optimistic on FTRE, with a "Hold" consensus rating and $18.17 price target (18.7% upside). 5 of 12 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do FTRE price targets vary so much?
FTRE analyst price targets range from $14 to $25, a 61% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.17 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare